Body composition and serum prostate-specific antigen: Review and findings from Flint Men's Health Study

被引：27

作者：

Beebe-Dimmer, Jennifer L.

Faerber, Gary J.

Morgenstern, Hal

Werny, David

Wojno, Kirk

Halstead-Nussloch, Bronwen

Cooney, Kathleen A.

机构：

[1] Wayne State Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA

[2] Wayne State Sch Med, Dept Internal Med, Detroit, MI 48201 USA

[3] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA

[4] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA

[5] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA

来源：

UROLOGY | 2008年 / 71卷 / 04期

关键词：

D O I：

10.1016/j.urology.2007.11.049

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies have suggested that obesity is associated with lower serum prostate-specific antigen levels, perhaps influencing the recommendation for prostate biopsy and potentially explaining part of the observed poorer prognosis among obese men. African-American men have the greatest rates of prostate cancer and are more likely to die of the disease, making early detection a priority in this group. We present findings from the Flint Men's Health Study, a study of African-American men, that are consistent with Most Studies Suggesting that overweight men have prostate-specific antigen levels that are 0.15 to 0.30 n-/mL lower than those who are not overweight. We have coupled our results with a systematic review Of publications in this area.

引用

页码：554 / 560

页数：7

共 43 条

[31] Association between insulin-like growth factor-I:insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women
Sandhu, MS
Gibson, JM
Heald, AH
Dunger, DB
Wareham, NJ
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (01) : 166 - 170
[32] Advances in cancer epidemiology: Understanding causal mechanisms and the evidence for implementing interventions
Schottenfeld, D
Beebe-Dimmer, JL
[J]. ANNUAL REVIEW OF PUBLIC HEALTH, 2005, 26 : 37 - 60
[33] Prostate cancer screening practices and cancer control research (United States)
Schottenfeld, D
Colditz, GA
[J]. CANCER CAUSES & CONTROL, 2002, 13 (01) : 1 - 5
[34] Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men
Smith, DS
Carvalhal, GF
Mager, DE
Bullock, AD
Catalona, WJ
[J]. JOURNAL OF UROLOGY, 1998, 160 (05) : 1734 - 1738
[35] PROSTATE-SPECIFIC ANTIGEN AS A SERUM MARKER FOR ADENOCARCINOMA OF THE PROSTATE
STAMEY, TA
YANG, N
HAY, AR
MCNEAL, JE
FREIHA, FS
REDWINE, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15) : 909 - 916
[36] The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
Stamey, TA
Caldwell, M
McNeal, JE
Nolley, R
Hemenez, M
Downs, J
[J]. JOURNAL OF UROLOGY, 2004, 172 (04) : 1297 - 1301
[37] Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy
Strom, SS
Wang, XM
Pettaway, CA
Logothetis, C
Yamamura, Y
Do, KA
Babaian, RJ
Troncoso, P
[J]. CLINICAL CANCER RESEARCH, 2005, 11 (19) : 6889 - 6894
[38] Prostate cancer and prostate-specific antigen: The more we know, the less we understand
Thompson, I
Leach, RJ
Pollock, BH
Naylor, SL
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14): : 1027 - 1028
[39] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
Thompson, IM
Pauler, DK
Goodman, PJ
Tangen, CM
Lucia, MS
Parnes, HL
Minasian, LM
Ford, LG
Lippman, SM
Crawford, ED
Crowley, JJ
Coltman, CA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) : 2239 - 2246
[40] Relationship of body mass index and prostate specific antigen in a population-based study
Thompson, IM
Leach, R
Troyer, D
Pollock, B
Naylor, S
Higgins, B
[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (02) : 127 - 131

← 1 2 3 4 5 →